[ETTN (11) Roster]

This study section reviews SBIR and STTR applications concerned with the diagnosis and treatment of neurological and psychiatric disease. Applications include medicinal chemistry studies aimed at identifying lead therapeutic compounds or developing new diagnostic products.  Other applications may focus on Investigational New Drug (IND) enabling studies or Proof-Of-Concept clinical studies on either IND approved agents or new indications for previously approved therapeutics. Emphasis is placed on the near term development of specific products with commercial viability being an important consideration. Specific areas covered by ETTN (11) include:

• Neuropathological events such as Stroke, Spinal Cord Injury and Traumatic Brain Injury.
• Neurodegenerative disorders such as Multiple Sclerosis, Alzheimer’s, Huntington’s and Parkinson’s diseases.
• Psychiatric disorders such as Autism, Depression and Schizophrenia.
• Neurological disorders such as Chronic pain, Migraine and Neuropathic pain.
• Alcoholism and Drug Addiction.

Study sections with most closely related areas of similar science listed in rank order are:

With the Genes, Genomes and Genetics [GGG] IRG 
With the Risk, Prevention and Health Behavior [RPHB] IRG 
With the Biobehavioral and Behavioral Processes [BBBP] IRG 
With the Musculoskeletal, Oral, and Skin Sciences [MOSS] IRG 
With the Biology of Development and Aging [BDA] IRG